Action and Reaction: The Biological Response to siRNA and Its Delivery Vehicles

Pathogen Recognition and Innate Immunity

Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,952

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304

Pattern Recognition Receptors and Inflammation

Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247

Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527

Prediction of Mammalian MicroRNA Targets

Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199

Toll-like receptors: critical proteins linking innate and acquired immunity

Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755

Combinatorial microRNA target predictions

Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947

Atomic structure and chemistry of human serum albumin

He, X. M., & Carter, D. C. (1992) · Nature · doi:10.1038/358209a0 · Cited by 3,824

Regulated portals of entry into the cell

Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805

Factors affecting the clearance and biodistribution of polymeric nanoparticles

Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699

The TNF and TNF Receptor Superfamilies

Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650

Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles

OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637

Delivering nanomedicine to solid tumors

Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180

Knocking down barriers: advances in siRNA delivery

Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115

Asymmetry in the Assembly of the RNAi Enzyme Complex

Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922

Functional siRNAs and miRNAs exhibit strand bias

Khvorova, A., Reynolds, A., & Jayasena, S. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00801-8 · Cited by 2,645

5'-Triphosphate RNA Is the Ligand for RIG-I

Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474

Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment

Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438

Expression profiling reveals off-target gene regulation by RNAi

Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370

Toxicity of cationic lipids and cationic polymers in gene delivery

Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates

Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F., & Reis e Sousa, C. (2006) · Science · doi:10.1126/science.1132998 · Cited by 2,210

Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs

Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183

Rational siRNA design for RNA interference

Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W. S., & Khvorova, A. (2004) · Nature Biotechnology · doi:10.1038/nbt936 · Cited by 2,094

Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals

Xie, X., Lu, J., Kulbokas, E. J., Golub, T. R., Mootha, V., Lindblad-Toh, K., Lander, E. S., & Kellis, M. (2005) · Nature · doi:10.1038/nature03441 · Cited by 1,872

Rational design of cationic lipids for siRNA delivery

Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822

Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms

Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255691.76142.4a · Cited by 1,750

Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness

Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689

Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677

Specificity of microRNA target selection in translational repression

Doench, J. G., & Sharp, P. A. (2004) · Genes & Development · doi:10.1101/gad.1184404 · Cited by 1,636

Pathways of clathrin-independent endocytosis

Mayor, S., & Pagano, R. E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2216 · Cited by 1,556

Nanocarriers’ entry into the cell: relevance to drug delivery

Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552

The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution

Farh, K. K.-H., Grimson, A., Jan, C., Lewis, B. P., Johnston, W. K., Lim, L. P., Burge, C. B., & Bartel, D. P. (2005) · Science · doi:10.1126/science.1121158 · Cited by 1,484

Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation

Lai, E. C. (2002) · Nature Genetics · doi:10.1038/ng865 · Cited by 1,473

Cell Type-Specific Involvement of RIG-I in Antiviral Response

Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., Tsujimura, T., Takeda, K., Fujita, T., Takeuchi, O., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.010 · Cited by 1,368

RNAi-mediated gene silencing in non-human primates

Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357

Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis

Akinc, A., Thomas, M., Klibanov, A. M., & Langer, R. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.696 · Cited by 1,337

Endocytosis

Mukherjee, S., Ghosh, R. N., & Maxfield, F. R. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.759 · Cited by 1,294

Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms

Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261

Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds

Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255690.03436.ae · Cited by 1,257

Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250

Virus Entry: Open Sesame

Marsh, M., & Helenius, A. (2006) · Cell · doi:10.1016/j.cell.2006.02.007 · Cited by 1,186

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,150

MicroRNAs direct rapid deadenylation of mRNA

Wu, L., Fan, J., & Belasco, J. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510928103 · Cited by 1,138

A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy

Moghimi, S. M., Symonds, P., Murray, J. C., Hunter, A. C., Debska, G., & Szewczyk, A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.02.010 · Cited by 1,092

Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application

Jackson, A. L., & Linsley, P. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3010 · Cited by 1,083

Endocytic mechanisms for targeted drug delivery☆

BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033

Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases

Caron, E., & Hall, A. (1998) · Science · doi:10.1126/science.282.5394.1717 · Cited by 1,019

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon

Meurs, E., Chong, K., Galabru, J., Thomas, N. S. B., Kerr, I. M., Williams, B. R. G., & Hovanessian, A. G. (1990) · Cell · doi:10.1016/0092-8674(90)90374-n · Cited by 1,017

ATP Requirements and Small Interfering RNA Structure in the RNA Interference Pathway

Nykänen, A., Haley, B., & Zamore, P. D. (2001) · Cell · doi:10.1016/s0092-8674(01)00547-5 · Cited by 1,016

Tumor-Selective Delivery of Macromolecular Drugs via the EPR Effect: Background and Future Prospects

Maeda, H. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100070g · Cited by 998

Mechanisms and optimization of in vivo delivery of lipophilic siRNAs

Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974

Lipid-like materials for low-dose, in vivo gene silencing

Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910603106 · Cited by 969

Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics

Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D., Wain, J., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 967

Ribonuclease A

Raines, R. T. (1998) · Chemical Reviews · doi:10.1021/cr960427h · Cited by 937

3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets

Birmingham, A., Anderson, E. M., Reynolds, A., Ilsley-Tyree, D., Leake, D., Fedorov, Y., Baskerville, S., Maksimova, E., Robinson, K., Karpilow, J., et al. (2006) · Nature Methods · doi:10.1038/nmeth854 · Cited by 920

Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente

García-Sastre, A., & Biron, C. A. (2006) · Science · doi:10.1126/science.1125676 · Cited by 885

siRNA function in RNAi: A chemical modification analysis

CHIU, Y.-L., & RANA, T. M. (2003) · RNA · doi:10.1261/rna.5103703 · Cited by 860

Therapeutic siRNA silencing in inflammatory monocytes in mice

Leuschner, F., Dutta, P., Gorbatov, R., Novobrantseva, T. I., Donahoe, J. S., Courties, G., Lee, K. M., Kim, J. I., Markmann, J. F., Marinelli, B., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1989 · Cited by 839

Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing

Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 789

Parameters influencing the stealthiness of colloidal drug delivery systems

Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740

Macropinocytosis

Swanson, J. A., & Watts, C. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)89101-1 · Cited by 733

Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging

Vakoc, B. J., Lanning, R. M., Tyrrell, J. A., Padera, T. P., Bartlett, L. A., Stylianopoulos, T., Munn, L. L., Tearney, G. J., Fukumura, D., Jain, R. K., et al. (2009) · Nature Medicine · doi:10.1038/nm.1971 · Cited by 719

Design and gene delivery activity of modified polyethylenimines

Kircheis, R., Wightman, L., & Wagner, E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00202-2 · Cited by 651

Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates

Frank-Kamenetsky, M., Grefhorst, A., Anderson, N. N., Racie, T. S., Bramlage, B., Akinc, A., Butler, D., Charisse, K., Dorkin, R., Fan, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805434105 · Cited by 642

Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System

Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635

Breaking down the barriers: siRNA delivery and endosome escape

Dominska, M., & Dykxhoorn, D. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.066399 · Cited by 630

On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids

Hafez, I., Maurer, N., & Cullis, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601

Sequence-specific inhibition of small RNA function

Hutvágner, G., Simard, M. J., Mello, C. C., & Zamore, P. D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020098 · Cited by 584

In vivo activity of nuclease-resistant siRNAs

LAYZER, J. M., MCCAFFREY, A. P., TANNER, A. K., HUANG, Z., KAY, M. A., & SULLENGER, B. A. (2004) · RNA · doi:10.1261/rna.5239604 · Cited by 580

POROUS SUBSTRUCTURE OF THE GLOMERULAR SLIT DIAPHRAGM IN THE RAT AND MOUSE

Rodewald, R., & Karnovsky, M. J. (1974) · The Journal of Cell Biology · doi:10.1083/jcb.60.2.423 · Cited by 579

Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality

Elm n, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki193 · Cited by 559

Molecular Basis for Target RNA Recognition and Cleavage by Human RISC

Ameres, S. L., Martinez, J., & Schroeder, R. (2007) · Cell · doi:10.1016/j.cell.2007.04.037 · Cited by 559

Sheddable Coatings for Long-Circulating Nanoparticles

Romberg, B., Hennink, W. E., & Storm, G. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9348-7 · Cited by 555

Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation

Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549

The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation

Kedmi, R., Ben-Arie, N., & Peer, D. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.05.027 · Cited by 546

Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs

Khan, A. A., Betel, D., Miller, M. L., Sander, C., Leslie, C. S., & Marks, D. S. (2009) · Nature Biotechnology · doi:10.1038/nbt.1543 · Cited by 534

Specificity of short interfering RNA determined through gene expression signatures

Semizarov, D., Frost, L., Sarthy, A., Kroeger, P., Halbert, D. N., & Fesik, S. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131959100 · Cited by 501

Off-target effects by siRNA can induce toxic phenotype

Fedorov, Y., Anderson, E. M., Birmingham, A., Reynolds, A., Karpilow, J., Robinson, K., Leake, D., Marshall, W. S., & Khvorova, A. (2006) · RNA · doi:10.1261/rna.28106 · Cited by 490

Untitled work

(2000) · PubMed · Cited by 475

Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows.

Yuan, F., Salehi, H. A., Boucher, Y., Vasthare, U. S., Tuma, R. F., & Jain, R. K. (1994) · PubMed · Cited by 463

Tumor Microvasculature and Microenvironment: Novel Insights Through Intravital Imaging in Pre-Clinical Models

FUKUMURA, D., DUDA, D. G., MUNN, L. L., & JAIN, R. K. (2010) · Microcirculation · doi:10.1111/j.1549-8719.2010.00029.x · Cited by 451

siRNA and Innate Immunity

Robbins, M., Judge, A., & MacLachlan, I. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0180 · Cited by 449

Lipid‐based nanotherapeutics for siRNA delivery

Schroeder, A., Levins, C. G., Cortez, C., Langer, R., & Anderson, D. G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02189.x · Cited by 447

Neovasculature induced by vascular endothelial growth factor is fenestrated.

Roberts, W. G., & Palade, G. E. (1997) · PubMed · Cited by 446

Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation

Wong, C. C.-L., Gilkes, D. M., Zhang, H., Chen, J., Wei, H., Chaturvedi, P., Fraley, S. I., Wong, C.-M., Khoo, U.-S., Ng, I. O.-L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113483108 · Cited by 437

Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles

Leventis, R., & Silvius, J. R. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90017-i · Cited by 430

Design of a genome-wide siRNA library using an artificial neural network

Huesken, D., Lange, J., Mickanin, C., Weiler, J., Asselbergs, F., Warner, J., Meloon, B., Engel, S., Rosenberg, A., Cohen, D., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1118 · Cited by 386

Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase

Kim, D.-H., Longo, M., Han, Y., Lundberg, P., Cantin, E., & Rossi, J. J. (2004) · Nature Biotechnology · doi:10.1038/nbt940 · Cited by 382

A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells

Marques, J. T., Devosse, T., Wang, D., Zamanian-Daryoush, M., Serbinowski, P., Hartmann, R., Fujita, T., Behlke, M. A., & Williams, B. R. (2006) · Nature Biotechnology · doi:10.1038/nbt1205 · Cited by 380

Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic Liposomes

Dokka, S., Toledo, D., Shi, X., Castranova, V., & Rojanasakul, Y. (2000) · Pharmaceutical Research · doi:10.1023/a:1007504613351 · Cited by 349

The role of interleukins in insulin resistance and type 2 diabetes mellitus

Fève, B., & Bastard, J.-P. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.62 · Cited by 343

Development of Lipidoid–siRNA Formulations for Systemic Delivery to the Liver

Akinc, A., Goldberg, M., Qin, J., Dorkin, J. R., Gamba-Vitalo, C., Maier, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Manoharan, M., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.36 · Cited by 323

Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography

Wartiovaara, J., Öfverstedt, L.-G., Khoshnoodi, J., Zhang, J., Mäkelä, E., Sandin, S., Ruotsalainen, V., Cheng, R. H., Jalanko, H., Skoglund, U., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22562 · Cited by 319

Phagocytosis by zippers and triggers

Swanson, J. A., & Baer, S. C. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)88956-4 · Cited by 313

The impact of target site accessibility on the design of effective siRNAs

Tafer, H., Ameres, S. L., Obernosterer, G., Gebeshuber, C. A., Schroeder, R., Martinez, J., & Hofacker, I. L. (2008) · Nature Biotechnology · doi:10.1038/nbt1404 · Cited by 308

On the art of identifying effective and specific siRNAs

Pei, Y., & Tuschl, T. (2006) · Nature Methods · doi:10.1038/nmeth911 · Cited by 302

The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer

Wisse, E., Jacobs, F., Topal, B., Frederik, P., & De Geest, B. (2008) · Gene Therapy · doi:10.1038/gt.2008.60 · Cited by 289

Dynamin 2 Is Required for Phagocytosis in Macrophages

Gold, E. S., Underhill, D. M., Morrissette, N. S., Guo, J., McNiven, M. A., & Aderem, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1849 · Cited by 286

siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect

Naito, Y., Yoshimura, J., Morishita, S., & Ui-Tei, K. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-392 · Cited by 286

The Effect of Chemical Modification and Nanoparticle Formulation on Stability and Biodistribution of siRNA in Mice

Gao, S., Dagnaes-Hansen, F., Nielsen, E. J. B., Wengel, J., Besenbacher, F., Howard, K. A., & Kjems, J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.91 · Cited by 286

Overexpression of Exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs

YI, R., DOEHLE, B. P., QIN, Y., MACARA, I. G., & CULLEN, B. R. (2005) · RNA · doi:10.1261/rna.7233305 · Cited by 278

Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC

Castanotto, D., Sakurai, K., Lingeman, R., Li, H., Shively, L., Aagaard, L., Soifer, H., Gatignol, A., Riggs, A., & Rossi, J. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm543 · Cited by 269

Biodistribution of phosphodiester and phosphorothioate siRNA

Braasch, D. A., Paroo, Z., Constantinescu, A., Ren, G., Öz, O. K., Mason, R. P., & Corey, D. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.074 · Cited by 251

Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape

Endoh, T., & Ohtsuki, T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.005 · Cited by 242

Physicochemical Characterization and Purification of Cationic Lipoplexes

Xu, Y., Hui, S.-W., Frederik, P., & Szoka, F. C. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)76894-3 · Cited by 229

Molecular mechanisms of phagocytic uptake in mammalian cells

Groves, E., Dart, A. E., Covarelli, V., & Caron, E. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7578-4 · Cited by 227

Gene delivery by cationic lipid vectors: overcoming cellular barriers

Zuhorn, I. S., Engberts, J. B. F. N., & Hoekstra, D. (2007) · European Biophysics Journal · doi:10.1007/s00249-006-0092-4 · Cited by 224

Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specificity

Akhtar, S., & Benter, I. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.010 · Cited by 219

A Novel Mechanism Is Involved in Cationic Lipid-Mediated Functional siRNA Delivery

Lu, J. J., Langer, R., & Chen, J. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900023v · Cited by 219

The human RNA kinase hClp1 is active on 3′ transfer RNA exons and short interfering RNAs

Weitzer, S., & Martinez, J. (2007) · Nature · doi:10.1038/nature05777 · Cited by 211

Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery

van der Woude, I., Wagenaar, A., Meekel, A. A. P., ter Beest, M. B. A., Ruiters, M. H. J., Engberts, J. B. F. N., & Hoekstra, D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1160 · Cited by 209

Visualization of in vitro protein-rejecting properties of PEGylated stealth® polycyanoacrylate nanoparticles

Peracchia, M. T., Harnisch, S., Pinto-Alphandary, H., Gulik, A., Dedieu, J. C., Desmaële, D., d’Angelo, J., Müller, R. H., & Couvreur, P. (1999) · Biomaterials · doi:10.1016/s0142-9612(99)00021-6 · Cited by 208

Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity

Cubillos-Ruiz, J. R., Engle, X., Scarlett, U. K., Martinez, D., Barber, A., Elgueta, R., Wang, Nesbeth, Y., Durant, Gewirtz, A. T., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37716 · Cited by 208

Expression of shRNA From a Tissue-specific pol II Promoter Is an Effective and Safe RNAi Therapeutic

Giering, J. C., Grimm, D., Storm, T. A., & Kay, M. A. (2008) · Molecular Therapy · doi:10.1038/mt.2008.144 · Cited by 206

Lysosomal Enzyme Trafficking between Phagosomes, Endosomes, and Lysosomes in J774 Macrophages

Claus, V., Jahraus, A., Tjelle, T., Berg, T., Kirschke, H., Faulstich, H., & Griffiths, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9842 · Cited by 205

Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function

Minshall, R. D., Tiruppathi, C., Vogel, S. M., & Malik, A. B. (2002) · Histochemistry and Cell Biology · doi:10.1007/s00418-001-0367-x · Cited by 203

Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver

Grimm, D., Wang, L., Lee, J. S., Schürmann, N., Gu, S., Börner, K., Storm, T. A., & Kay, M. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43565 · Cited by 196

A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects

Bramsen, J. B., Pakula, M. M., Hansen, T. B., Bus, C., Langkjær, N., Odadzic, D., Smicius, R., Wengel, S. L., Chattopadhyaya, J., Engels, J. W., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq341 · Cited by 195

Silencing or Stimulation? siRNA Delivery and the Immune System

Whitehead, K. A., Dahlman, J. E., Langer, R. S., & Anderson, D. G. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114133 · Cited by 191

A Novel Series of Amphiphilic Imidazolinium Compounds for in Vitro and in Vivo Gene Delivery

Solodin, I., Brown, C. S., Bruno, M. S., Chow, C.-Y., Jang, E.-H., Debs, R. J., & Heath, T. D. (1995) · Biochemistry · doi:10.1021/bi00041a033 · Cited by 189

M-CSF-induced macropinocytosis increases solute endocytosis but not receptor-mediated endocytosis in mouse macrophages

Racoosin, E. L., & Swanson, J. A. (1992) · Journal of Cell Science · doi:10.1242/jcs.102.4.867 · Cited by 188

In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(–PEG)/siRNA complexes

Malek, A., Merkel, O., Fink, L., Czubayko, F., Kissel, T., & Aigner, A. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.01.014 · Cited by 185

New insights into the role of podocytes in proteinuria

Patrakka, J., & Tryggvason, K. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.108 · Cited by 185

Lack of interferon response in animals to naked siRNAs

Heidel, J. D., Hu, S., Liu, X. F., Triche, T. J., & Davis, M. E. (2004) · Nature Biotechnology · doi:10.1038/nbt1038 · Cited by 183

Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: Effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging

Merkel, O. M., Librizzi, D., Pfestroff, A., Schurrat, T., Buyens, K., Sanders, N. N., De Smedt, S. C., Béhé, M., & Kissel, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.016 · Cited by 183

Evaluation of locked nucleic acid–modified small interfering RNA in vitro and in vivo

Mook, O. R., Baas, F., de Wissel, M. B., & Fluiter, K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0195 · Cited by 182

Strand-specific 5′-O-methylation of siRNA duplexes controls guide strand selection and targeting specificity

Chen, P. Y., Weinmann, L., Gaidatzis, D., Pei, Y., Zavolan, M., Tuschl, T., & Meister, G. (2008) · RNA · doi:10.1261/rna.789808 · Cited by 176

Addressing the problem of cationic lipid-mediated toxicity: The magnetoliposome model

Soenen, S. J. H., Brisson, A. R., & De Cuyper, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.040 · Cited by 162

Methods To Evaluate Biliary Excretion of Drugs in Humans: An Updated Review

Ghibellini, G., Leslie, E. M., & Brouwer, K. L. R. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060011k · Cited by 160

CD44 is a phagocytic receptor

Vachon, E. (2006) · Blood · doi:10.1182/blood-2005-09-3808 · Cited by 159

Targeted Delivery Systems for Oligonucleotide Therapeutics

Yu, B., Zhao, X., Lee, L. J., & Lee, R. J. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9096-1 · Cited by 158

Glomerular basement membrane composition and the filtration barrier

Miner, J. H. (2011) · Pediatric Nephrology · doi:10.1007/s00467-011-1785-1 · Cited by 158

Update on the glomerular filtration barrier

Jarad, G., & Miner, J. H. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283296044 · Cited by 153

Elimination Pathways of Systemically Delivered siRNA

Huang, Y., Hong, J., Zheng, S., Ding, Y., Guo, S., Zhang, H., Zhang, X., Du, Q., & Liang, Z. (2010) · Molecular Therapy · doi:10.1038/mt.2010.266 · Cited by 152

Toxicogenomics of Non-viral Vectors for Gene Therapy: A Microarray Study of Lipofectin- and Oligofectamine-induced Gene Expression Changes in Human Epithelial Cells

Omidi, Y., Hollins, A. J., Benboubetra, M., Drayton, R. M., Benter, I. F., & Akhtar, S. (2003) · Journal of drug targeting · doi:10.1080/10611860310001636908 · Cited by 152

Erratum: Corrigendum: Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs

Khan, A. A., Betel, D., Miller, M. L., Sander, C., Leslie, C. S., & Marks, D. S. (2009) · Nature Biotechnology · doi:10.1038/nbt0709-671a · Cited by 151

UNA (unlocked nucleic acid): A flexible RNA mimic that allows engineering of nucleic acid duplex stability

Langkjær, N., Pasternak, A., & Wengel, J. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.06.045 · Cited by 150

MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity

Turner, J. J., Jones, S. W., Moschos, S. A., Lindsay, M. A., & Gait, M. J. (2006) · Molecular BioSystems · doi:10.1039/b611612d · Cited by 146

Inhibition of protein kinase C by cationic amphiphiles

Bottega, R., & Epand, R. M. (1992) · Biochemistry · doi:10.1021/bi00152a045 · Cited by 145

Design of siRNAs producing unstructured guide-RNAs results in improved RNA interference efficiency

Patzel, V., Rutz, S., Dietrich, I., Köberle, C., Scheffold, A., & Kaufmann, S. H. E. (2005) · Nature Biotechnology · doi:10.1038/nbt1151 · Cited by 142

OligoWalk: an online siRNA design tool utilizing hybridization thermodynamics

Lu, Z., & Mathews, D. H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn250 · Cited by 141

Target accessibility dictates the potency of human RISC

Brown, K. M., Chu, C., & Rana, T. M. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb931 · Cited by 133

Molecular make-up of the glomerular filtration barrier

Patrakka, J., & Tryggvason, K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.069 · Cited by 129

Toxicity Pathway Focused Gene Expression Profiling of PEI-Based Polymers for Pulmonary Applications

Beyerle, A., Irmler, M., Beckers, J., Kissel, T., & Stoeger, T. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900278x · Cited by 128

Biodistribution of Small Interfering RNA at the Organ and Cellular Levels after Lipid Nanoparticle-mediated Delivery

Shi, B., Keough, E., Matter, A., Leander, K., Young, S., Carlini, E., Sachs, A. B., Tao, W., Abrams, M., Howell, B., et al. (2011) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411410885 · Cited by 125

Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo

Laursen, M. B., Pakula, M. M., Gao, S., Fluiter, K., Mook, O. R. F., Baas, F., Langkjær, N., Wengel, S. L., Wengel, J., Kjems, J., et al. (2010) · Molecular BioSystems · doi:10.1039/b918869j · Cited by 121

Role of podocyte slit diaphragm as a filtration barrier (Review Article)

Kawachi, H., Miyauchi, N., Suzuki, K., Han, G. D., Orikasa, M., & Shimizu, F. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00583.x · Cited by 121

Mechanism of pH-Triggered Collapse of Phosphatidylethanolamine Liposomes Stabilized by an Ortho Ester Polyethyleneglycol Lipid

Guo, X. D., MacKay, J. A., & Szoka, F. C. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74986-8 · Cited by 116

Competition for RISC binding predicts in vitro potency of siRNA

Koller, E., Propp, S. S., Murray, H., Lima, W. F., Bhat, B., Prakash, T. P., Allerson, C. R., Swayze, E. E., Marcusson, E. G., & Dean, N. M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl589 · Cited by 115

Improved specificity of gene silencing by siRNAs containing unlocked nucleobase analogs

Vaish, N. K., Chen, F., Seth, S., Fosnaugh, K. L., Liu, Y., Adami, R. C., Brown, T., Chen, Y., Harvie, P., Johns, R. E., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq961 · Cited by 111

Polymer-related off-target effects in non-viral siRNA delivery

Merkel, O. M., Beyerle, A., Beckmann, B. M., Zheng, M., Hartmann, R. K., Stöger, T., & Kissel, T. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.081 · Cited by 107

Reduced levels of Ago2 expression result in increased siRNA competition in mammalian cells

Vickers, T. A., Lima, W. F., Nichols, J. G., & Crooke, S. T. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm663 · Cited by 95

Chemical Modification of siRNA

Deleavey, G. F., Watts, J. K., & Damha, M. J. (2009) · Current Protocols in Nucleic Acid Chemistry · doi:10.1002/0471142700.nc1603s39 · Cited by 91

Increased siRNA duplex stability correlates with reduced off-target and elevated on-target effects

Petri, S., Dueck, A., Lehmann, G. J., Putz, N., Rüdel, S., Kremmer, E., & Meister, G. (2011) · RNA · doi:10.1261/rna.2348111 · Cited by 75

Mechanistic Insights Aid Computational Short Interfering RNA Design

Boese, Q., Leake, D., Reynolds, A., Read, S., Scaringe, S. A., Marshall, W. S., & Khvorova, A. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)92005-8 · Cited by 68

The glomerulus – a view from the inside – the endothelial cell

Fogo, A. B., & Kon, V. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.05.015 · Cited by 68

Tolerated wobble mutations in siRNAs decrease specificity, but can enhance activity in vivo

Holen, T., Moe, S. E., Sorbo, J. G., Meza, T. J., Ottersen, O. P., & Klungland, A. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki785 · Cited by 62

“Alternative” endocytic mechanisms exploited by pathogens: New avenues for therapeutic delivery?☆

Medina‐Kauwe, L. K. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.009 · Cited by 58

Prediction of human pharmacokinetics—biliary and intestinal clearance and enterohepatic circulation

Fagerholm, U. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.5.0001 · Cited by 58

Elucidating the Encapsulation of Short Interfering RNA in PEGylated Cationic Liposomes

Buyens, K., Demeester, J., Smedt, S. C. D., & Sanders, N. N. (2009) · Langmuir · doi:10.1021/la803973p · Cited by 57

Differences between fluid-phase endocytosis (pinocytosis) and receptor-mediated endocytosis in isolated rat hepatocytes.

STRØMHAUG, P. E., Berg, T., Gjøen, T., & Seglen, P. O. (1997) · PubMed · Cited by 45

Drug Delivery–mediated Control of RNA Immunostimulation

Nguyen, D. N., Chen, S., Lu, J. J., Goldberg, M. S., Kim, P., Sprague, A., Novobrantseva, T., Sherman, J., Shulga-Morskaya, S., de Fougerolles, A., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.147 · Cited by 34

1,2-Dioleoyl-3-Trimethylammonium-Propane (DOTAP)-Formulated, Immune-Stimulatory Vascular Endothelial Growth Factor A Small Interfering RNA (siRNA) Increases Antitumoral Efficacy in Murine Orthotopic Hepatocellular Carcinoma with Liver Fibrosis

Kornek, M., Kornek, M., Limmer, A., Raskopf, E., Becker, U., Klöckner, M., Sauerbruch, T., & Schmitz, V. (2008) · Molecular Medicine · doi:10.2119/2008-00003.kornek · Cited by 22

Selecting effective siRNAs based on guide RNA structure

Köberle, C., Kaufmann, S. H. E., & Patzel, V. (2006) · Nature Protocols · doi:10.1038/nprot.2006.206 · Cited by 20

Non-viral vectors for gene-based therapy

Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123

Delivery materials for siRNA therapeutics

Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800

mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases

Maruggi, G., Zhang, C., Li, J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.020 · Cited by 507

RNAi Efficiency, Systemic Properties, and Novel Delivery Methods for Pest Insect Control: What We Know So Far

Joga, M. R., Zotti, M. J., Smagghe, G., & Christiaens, O. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00553 · Cited by 521

Multifunctional polymeric micelles for delivery of drugs and siRNA

Jhaveri, A. M., & Torchilin, V. P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00077 · Cited by 466